Argentarii
SUPN icon

Argentarii’s Supernus Pharmaceuticals SUPN Stock Holding History

Argentarii’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$323K Hold
7,500
– – 0.1% 160
2026
Q2 		$352K Hold
7,500
– – 0.11% 158
2026
Q1 		$388K Hold
7,500
– – 0.14% 136
2025
Q4 		$373K Hold
7,500
– – 0.12% 139
2025
Q3 		$358K Hold
7,500
– – 0.14% 112
2025
Q2 		$236K Hold
7,500
– – 0.11% 139
2025
Q1 		$246K Hold
7,500
– – 0.12% 138
2024
Q4 		$271K Buy
+7,500
New +$264K 0.14% 125

Other funds holding SUPN

Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Campbell Newman Asset Management
Campbell Newman Asset Management Milwaukee, Wisconsin $1.33B AUM 26.63% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Oak Ridge Investments
Oak Ridge Investments Chicago, Illinois $1.68B AUM 48.52% 1-Year Est. Return
MAM
Mystic Asset Management Warwick, Rhode Island $451M AUM 22.13% 1-Year Est. Return

Argentarii's SUPN Position: Q3 2026 in Review

Argentarii held its Supernus Pharmaceuticals (SUPN) position steady in Q3 2026 at 7,500 shares worth $323K. The position accounts for 0.1% of the portfolio, ranked #160.

Argentarii first reported a position in SUPN in Q4 2024 and has held it in 8 quarters since. The position peaked at $388K in Q1 2026. 78 funds tracked by Wall St. Rank hold SUPN as of Q3 2026.

  • Argentarii held 7,500 shares of Supernus Pharmaceuticals worth $323K as of Q3 2026.
  • Argentarii left its Supernus Pharmaceuticals share count unchanged in Q3 2026.
  • Supernus Pharmaceuticals made up 0.1% of Argentarii's portfolio in Q3 2026, its #160 holding.
  • Argentarii first reported a position in Supernus Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • Argentarii's Supernus Pharmaceuticals position peaked at $388K in Q1 2026.
  • 78 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2026.

Based on Argentarii's 13F filing for Q3 2026, filed 28 Oct 2026.